Navigation Links
Vaccine for Pancreatic Cancer Halts Progression of Disease in Some Patients

A dendritic cell-based therapeutic vaccine for pancreatic cancer developed has successfully stalled the disease from progressing in a handful of patients three years// post-vaccination. The results provide promising evidence that the vaccine can trigger a patient’s own immune system to rally against pancreatic cancer and offer new insights into how the vaccine could be made even more effective.

"Pancreatic cancer is extremely resistant to chemotherapy and radiation and, as a result, has a very high mortality rate," said Andrew Lepisto, Ph.D., first author of the study and post-doctoral researcher, department of immunology, University of Pittsburgh School of Medicine. "One strategy to improve the odds of survival is to help the immune system recognize the presence of pancreatic cancer cells and attack them. Our study, although small, demonstrates that this strategy can be used with some success in pancreatic cancer patients by slowing down, or even stopping, the progression of cancer."

The Pitt team created a therapeutic vaccine for pancreatic cancer made up of a synthetic version of MUC1 – a tumor-associated protein that is expressed by pancreatic tumor cells – combined with the patient’s own dendritic cells, which act as the quarterbacks of the immune system by coordinating its attack against foreign invaders.

The current study, the fourth in a series of MUC1 vaccine trials at the University of Pittsburgh School of Medicine, included 12 patients with pancreatic cancer who received the vaccine by injection once every three weeks for a total of three doses and were given a booster dose six months later. Four patients demonstrated a stable and continuous presence of antibodies against MUC1 and have no evidence of disease more than three years after the vaccination was completed and close to five years after diagnosis and surgery.

The research team also examined the specific immune response to the vaccine by sampling
'"/>




Page: 1 2

Related medicine news :

1. Vaccine to quit smoking?
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Vaccine for Alzheimer’s diseas
4. Health Officials Recommend Flu Vaccine
5. Smallpox Vaccine May Help Fight Cervical Cancer
6. Panacea Biotech To Market Anthrax Vaccine
7. New Prostate Cancer Vaccine Shows Promise
8. Drug Firm Offers to Donate Smallpox Vaccine
9. Vaccine guards against shingles
10. Vaccine for septic conditions
11. A new Vaccine for Pneumonia

Post Your Comments:
(Date:12/3/2009)... Mario Badescu Skin Care,s cult favorite ... 55 products receiving a 2009 ELLE Beauty Award ,...-- Mario Badescu Skin Care,s Drying Lotion has lon...ndustry insiders, and skin care divas, but its sel...d marks a considerable leap into the mainstream li...
(Date:12/3/2009)... Economic downturn causes demand for affo...de in Connecticut cites a sharp increase in demand...economic crisis which has led to an increase in al...blems. , (PRWEB) December...tment Center sees a huge spike in demand for its s...
(Date:12/3/2009)...ings, doubts linger about whether they cause brain...y News) -- Whether cell phones cause brain cancer ...udy confirms previous evidence suggesting that the...ts of brain tumors in Scandinavia found no substan...e became widespread, according to the report in th...
(Date:12/3/2009)...A JOLLA, Calif., Dec. 3 ...Biological Studies unanimously voted to elect thr...lla. ,, Fred Dotzler is co-founder and Managi...f. De Novo is investing $650 million from three fu...y companies. Dotzler founded Medicus Venture Partn...
(Date:12/3/2009)... Recent CBO analysis understates key factors contr...Newswire-USNewswire/ -- A new actuarial analysis b...ical claims in the new individual market will be 5...ter implementation of healthcare reform under the ..., excluding the impact of medical inflation. This...
Breaking Medicine News(10 mins):Health News:Economic Crisis Causes Acute Demand for Affordable Drug Addiction Treatment 2Health News:No Increase in Brain Tumors Seen From Cell Phones 2Health News:No Increase in Brain Tumors Seen From Cell Phones 3Health News:Salk Institute Board of Trustees Elects Leaders in Venture Capital and Publishing to its Membership 2Health News:New Actuarial Analysis Shows Senate Bill Would Significantly Raise Premiums 2Health News:New Actuarial Analysis Shows Senate Bill Would Significantly Raise Premiums 3Health News:New Actuarial Analysis Shows Senate Bill Would Significantly Raise Premiums 4
...009 AMERIGROUP Corporation (NYSE: AGP ) today... Sachs Leveraged Finance Healthcare Conference on ... the Company,s presentation, which begins Wednesda...able for 30 days, and can be accessed at the same ...
...Quantum Group, Inc. (NYSE Amex: QGP ) ( www.Quan...Companies Inc. to enhance its investor relations o...n their long-history of success in broadening visi...el J. Guillama, Chief Executive Officer of The Qua...
...Newswire-Asia-FirstCall/ -- Tianyin,Pharmaceutical...nd supplier of,modernized traditional Chinese medi...ced that the Board of Directors declared an annual...ers, the initial,dividend of $.025 will be paid to...
...g the risks of burns, skin cancer and premature ag...ation. But with the founding of her new company, I...ngbeds.com ), and this week,s launch of an economy...re a far cry from tanning beds popular a decade ag...
...looks to improve operating efficiencies with advan...mline Health Solutions, Inc. (Nasdaq: STRM ) ann... -affiliated surgery department will implement Str...ced Cloud Computing Center. The deployment of Str...
...rt entitled The Finnish Health,Care System: A Valu...ectives,on the development needs of health care in...model on value-based health care to analyze Finnis... analysing the,effectiveness of health care. One o...
Other Medicine News:Health News:The Quantum Group Announces Engagement of RedChip Companies for Investor Relations Programs 2Health News:The Quantum Group Announces Engagement of RedChip Companies for Investor Relations Programs 3Health News:Tianyin Pharmaceutical Co., Inc. Announces Cash Dividend to Common Stockholders 2Health News:Island Sun Tanning Beds Launches Economy-Buster Sale on Healthier, More Eco-friendly Home Tanning Beds 2Health News:Streamline Health to Deliver Hosted Document Workflow Solution to Leading West Coast University-Affiliated Surgery Department 2Health News:Streamline Health to Deliver Hosted Document Workflow Solution to Leading West Coast University-Affiliated Surgery Department 3Health News:Streamline Health to Deliver Hosted Document Workflow Solution to Leading West Coast University-Affiliated Surgery Department 4Health News:Finland Seeks Systemic Changes in Health Care 2
(Date:12/3/2009)...nn., Dec. 3 Cumberland ...oday that data from a recent clinical trial for Ca...us treatment for pain and fever, will be presented...rmacists (ASHP) Midyear Clinical Meeting in Las Ve... be displayed in a poster presentation on Monday, ...
(Date:12/3/2009)... 3 Alzheimer,s disease (AD) is one...receive. This irreversible, progressive brain dise... eventually even the ability to carry out the simp...g older people, AD affects as many as 2.4 million ...l Institute on Aging. ,, (Logo: http://www.n...
(Date:12/3/2009)... Calif., Dec. 3 Each yea...the United States (U.S.) and Europe participate in...atory experience under renowned faculty members at... Scholars - past, present and future - will have e...nity at www.amgenscholars.com . ,, "The new W...
Breaking Medicine Technology:New Caldolor(R) (ibuprofen) Injection Data to Be Presented at 44th American Society of Health-System Pharmacists Meeting 2New Caldolor(R) (ibuprofen) Injection Data to Be Presented at 44th American Society of Health-System Pharmacists Meeting 3Alzheimer's Research May Lead to Preventing the Debilitating Disease 2Alzheimer's Research May Lead to Preventing the Debilitating Disease 3New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists 2New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists 3Hummer owners claim moral high ground to excuse overconsumption 10002 1Hummer owners claim moral high ground to excuse overconsumption 10002 2Veterans Healing Initiative Formed to Help Meet Burgeoning Addiction and Mental Health Issues of Returning U S Veterans 57835 1Veterans Healing Initiative Formed to Help Meet Burgeoning Addiction and Mental Health Issues of Returning U S Veterans 57835 2Binge Drinking May Encourage Infection 57831 1
...irst RNA Antagonist Medicine to Be Tested in Patie...en, 6th June 2007 - Santaris Pharma, the Danish,bi...996, the,Company,s new RNA Antagonist of Bcl-2, ha...hase I/II clinical study in Chronic,Lymphocytic Le...ted,this week at the 2007 Annual Meeting of the Am...
...ust,s lead molecule, FP0011, exhibited a different...tolerance in mid- to,late-stage patients, STRASBOU....A., a,clinical stage product company specializing...eases of the nervous system, today,announced that ...molecule glutamate release inhibitor, FP0011, are ...
Other Medicine Technology:Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 2Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 3Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 4Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 5Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 6Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 7Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 8Santaris Pharma Presents Positive Clinical Data on SPC2996 in,Chronic Lymphocytic Leukaemia 9Faust Pharmaceuticals' Phase IIa Results for Parkinson's Disease,Presented at International Congress of Parkinson's Disease and,Movement Disorders 2Faust Pharmaceuticals' Phase IIa Results for Parkinson's Disease,Presented at International Congress of Parkinson's Disease and,Movement Disorders 3Faust Pharmaceuticals' Phase IIa Results for Parkinson's Disease,Presented at International Congress of Parkinson's Disease and,Movement Disorders 4
Irrigating Cystotome, Formed, 23 g
Retrobulbar Needle, 25 g. Atkinson style bevel.
Peribulbar Needle, 23 g. Atkinson style bevel.
Scleral Blade tip 5700 style, straight
Medicine Products: